New care plan improves Crohns disease complication outcomes
The first published medical and surgical approach care plan for managing septic perianal Crohns disease a serious complication that occurs in around 40 percent of Crohns disease patients has been...
View ArticleFINCH filgotinib Phase 3 program initiated in rheumatoid arthritis
Three studies addressing a broad population of patients with active rheumatoid arthritis Filgotinib 100 mg and 200 mg once daily dosing in males and females worldwide in combination and as monotherapy...
View ArticleNew care plan improves outcomes for Crohn's disease complication
Penn State The first published combined medical and surgical care plan for managing septic perianal Crohn's disease a serious complication that occurs in around 40 percent of Crohn's disease patients...
View Article4D pharma starts dosing in phase 1 trial with Thetanix to treat Paediatric...
4D pharma has started dosing in a phase 1 clinical trial with Thetanix for the treatment of Paediatric Crohn's disease 'PCD'.
View ArticlePenn scientists develop combined medical and surgical care plan for managing...
The first published combined medical and surgical care plan for managing septic perianal Crohn's disease a serious complication that occurs in around 40 percent of Crohn's disease patients has been...
View ArticleNew research shows impact of Crohn's disease on brain function
SAGE New research published in the UEG Journal has found that Crohn's disease sufferers experience slower response times than matched individuals that do not have the disease.
View ArticleCase Western Reserve researchers receive major NIH renewal grant to build on...
Case Western Reserve University Case Western Reserve University School of Medicine researcher has been awarded a grant with the goal of better understanding the origins of Crohn's disease and...
View ArticlePreventive Health Pioneer Dr. Michael McNamara Joins uBiomes Advisory Board
uBiome the leader in microbial genomics welcomes Dr. Michael McNamara to its scientific advisory board. Dr. McNamara is the Medical Director at Dr. McNamara Premium Healthcare in Monaco which...
View ArticleRedHill Biopharma Announces Approval of a European Patent Supporting RHB104...
RedHill has received from the European Patent Office a Notice of Intention to Grant a new patent covering RHB104 for multiple sclerosis MS expected to be valid until 2032 once granted A Phase IIa...
View Article180 Medical Announces Its 2016 College Scholarship Program Recipients
Each year 180 Medical chooses seven students as recipients of its annual college scholarship program which was designed to help those under a doctors care for a spinal cord injury or other approved...
View ArticleuBiome Hires New Vice President of Research and Development Dr. Audrey...
Microbial genomics leader uBiome welcomes genomics research luminary Dr. Audrey Goddard Ph.D. to the position of Vice President of Research and Development.San Francisco CA PRWEB September 01 2016...
View ArticleCROHN De l'intestin au cerveau une maladie multisystmique UEGJ
Cette nouvelle étude montre l'impact de la maladie de Crohn sur la fonction cérébrale des symptômes de déficience cognitive...
View ArticleArena Pharmaceutics Announces Formation of Beacon Discovery
SAN DIEGO Sept. 1 2016 PRNewswire &160;Arena Pharmaceuticals Inc. NASDAQ ARNA today announced the formation of Beacon Discovery Inc. "Beacon" an independent privatelyheld drug discovery...
View ArticleSmoking Linked to Higher Relapse Risk After Surgery for Crohn's
THURSDAY Sept. 1 2016 Smoking increases the risk that Crohn's disease patients will have relapses after bowel surgery new research suggests.The study included 240 Crohn's disease patients in the United...
View ArticleDiscovery offers hope for new Crohn's disease treatment
University of British Columbia Scientists at the University of British Columbia have made a discovery that could potentially lead to treatments for a debilitating complication of Crohn's disease.
View ArticleNew discovery could potentially lead to treatmentsÂfor Crohn's disease
Scientists at the University of British Columbia have made a discovery that could potentially lead to treatments for a debilitating complication of Crohn's disease.
View ArticleMedical News Today Crohn's disease Potential treatment to prevent fibrosis...
Scientists have made a significant discovery in understanding the cause of fibrosis in Crohn's disease which offers a target for potential therapies.
View ArticleNew hope for new Crohn's disease treatment
Scientists have made a discovery that could potentially lead to treatments for a debilitating complication of Crohn's disease.
View ArticleStudy identifies immune cells critical for the development of fibrosis in...
It is known that patients with Crohns disease have uncontrolled inflammation in their gut which can lead to intestinal fibrosis and narrowing that can slow or block the movement of food. When fibrosis...
View ArticleNext Up for Celgene's Crohn's Pill A Snapshot Inside Patients' Colons Updated
Click to view a price quote on CELG. Click to research the Drugs industry.
View Article